These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1779405)

  • 1. Comparative study of certain antibiotics on epileptogenic property, including (1Rpi, 5S, 6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)] thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate (LJC10627), a carbapenem antibiotic with broad antimicrobial spectrum.
    Kamei C; Kitazumi K; Tsujimoto S; Yoshida T; Tasaka K
    J Pharmacobiodyn; 1991 Sep; 14(9):509-17. PubMed ID: 1779405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.
    Horiuchi M; Kimura M; Tokumura M; Hasebe N; Arai T; Abe K
    Toxicology; 2006 May; 222(1-2):114-24. PubMed ID: 16549226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners.
    Jin C; Jung I; Ku HJ; Yook J; Kim DH; Kim M; Cho JH; Oh CH
    Toxicology; 1999 Nov; 138(2):59-67. PubMed ID: 10576583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteroaryliumthio substituted carbapenem derivatives: synthesis and in vitro activity of 1 beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems.
    Wildonger KJ; Ratcliffe RW
    J Antibiot (Tokyo); 1993 Dec; 46(12):1866-82. PubMed ID: 8294246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative stability of carbapenem and penem antibiotics to renal dehydropeptidase-I.
    Hikida M; Yoshida M; Mitsuhashi S
    Arzneimittelforschung; 1993 Jan; 43(1):71-3. PubMed ID: 8447852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptogenic activity induced by intravenous injection of certain cephalosporins in rats.
    Yu QH; Kitazumi K; Kamei C; Tasaka K
    J Pharmacobiodyn; 1984 Aug; 7(8):586-92. PubMed ID: 6512680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vivo nephrotoxicity in the rabbit by a pyrrolidinyl-thio Carbapenem CW-270031.
    Kim JM; Ha JR; Oh SW; Kim HG; Lee JM; Kim BO; Lee DG; Lee SH; Kim JG
    J Microbiol Biotechnol; 2008 Nov; 18(11):1768-72. PubMed ID: 19047819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem.
    Day IP; Goudie J; Nishiki K; Williams PD
    Toxicol Lett; 1995 Apr; 76(3):239-43. PubMed ID: 7762010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of seizures among the carbapenems: a meta-analysis.
    Cannon JP; Lee TA; Clark NM; Setlak P; Grim SA
    J Antimicrob Chemother; 2014 Aug; 69(8):2043-55. PubMed ID: 24744302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epileptogenic activity of cephalosporins in rats and their structure-activity relationship.
    Kamei C; Sunami A; Tasaka K
    Epilepsia; 1983 Aug; 24(4):431-9. PubMed ID: 6873002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative neurotoxicity of benzylpenicillin, imipenem/cilastatin and FCE 22101, a new injectible penem.
    Schliamser SE; Broholm KA; Liljedahl AL; Norrby SR
    J Antimicrob Chemother; 1988 Nov; 22(5):687-95. PubMed ID: 3209527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epileptogenic activity of methicillin-resistant Staphylococcus aureus (MRSA) antibiotics in rats.
    Rahman A; Ago J; Matsumoto N; Ishikawa T; Kamei C
    Biol Pharm Bull; 2006 Oct; 29(10):2035-40. PubMed ID: 17015947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834.
    Miyauchi M; Endo R; Hisaoka M; Yasuda H; Kawamoto I
    J Antibiot (Tokyo); 1997 May; 50(5):429-39. PubMed ID: 9207914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Convulsive liability of an oral carbapenem antibiotic, tebipenem pivoxil].
    Yagi Y; Nawa T; Kurata Y; Shibasaki S; Suzuki H; Kurosawa T
    Jpn J Antibiot; 2009 Jun; 62(3):241-52. PubMed ID: 19882983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
    Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
    Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carbapenems: new broad spectrum beta-lactam antibiotics.
    Moellering RC; Eliopoulos GM; Sentochnik DE
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():1-7. PubMed ID: 2681123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.
    Isoda T; Ushirogochi H; Satoh K; Takasaki T; Yamamura I; Sato C; Mihira A; Abe T; Tamai S; Yamamoto S; Kumagai T; Nagao Y
    J Antibiot (Tokyo); 2006 Apr; 59(4):241-7. PubMed ID: 16830892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.